Goldman Sachs Innovate Equity ETF (NYSEARCA:GINN – Get Free Report) shares rose 0.1% on Wednesday . The stock traded as high as $64.16 and last traded at $63.90. Approximately 3,431 shares changed hands during trading, a decline of 79% from the average daily volume of 16,197 shares. The stock had previously closed at $63.84.
Goldman Sachs Innovate Equity ETF Stock Performance
The company has a 50-day moving average of $61.54 and a 200-day moving average of $58.67. The stock has a market cap of $402.60 million, a price-to-earnings ratio of 26.00 and a beta of 1.25.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of the stock. New England Private Wealth Advisors LLC acquired a new stake in shares of Goldman Sachs Innovate Equity ETF in the 2nd quarter valued at approximately $380,000. Watts Gwilliam & Co. LLC acquired a new stake in shares of Goldman Sachs Innovate Equity ETF during the third quarter valued at $777,000. Flow Traders U.S. LLC purchased a new stake in Goldman Sachs Innovate Equity ETF in the 3rd quarter worth approximately $1,767,000. Finally, Highland Financial Advisors LLC lifted its position in Goldman Sachs Innovate Equity ETF by 14.7% during the second quarter. Highland Financial Advisors LLC now owns 222,414 shares of the company’s stock worth $12,622,000 after buying an additional 28,560 shares during the period.
About Goldman Sachs Innovate Equity ETF
The Goldman Sachs Innovate Equity ETF (GINN) is an exchange-traded fund that is based on the Solactive Innovative Global Equity index. The fund selects companies globally, believed to benefit from technological innovation and changes in the economy across five themes: data, finance, human evolution, manufacturing, and shifts with consumers.
Further Reading
- Five stocks we like better than Goldman Sachs Innovate Equity ETF
- How to Invest in Blue Chip Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Investing In Preferred Stock vs. Common Stock
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use the MarketBeat Dividend Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Goldman Sachs Innovate Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Goldman Sachs Innovate Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.